Pressreleases, rapporter och nyheter för Dancann Pharma
Press release from Companies: DanCann Pharma A/S: Tetra Bio-Pharma Submits Request for Scientific Advice to Malta Medicines Authority
Press release from Companies: DanCann Pharma A/S issues warrants to the Board of Directors
Press release from Companies: DanCann Pharma A/S Annual General Meeting 2021 and decisions by the Board of Directors
Press release from Companies: DanCann Pharma A/S: Market update for penetration of the Danish market, cf. the Danish Pilot Programme with medical cannabis
Press release from Companies: DanCann Pharma A/S: Tetra Bio-Pharma Provides an Update on its U.S. REBORN1 Clinical Trial
Press release from Companies: DanCann Pharma A/S has pressed the start button in BIOTECH PHARM1
Press release from Companies: DanCann Pharma A/S appoints Helle Bjerregaard as Head of Quality
Press release from Companies: Notice of Annual General Meeting of DanCann Pharma A/S
Press release from Companies: DanCann Pharma A/S publishes Annual Report 2020
Press release from Companies: DanCann Pharma A/S issues warrants to the executive management team
Press release from Companies: John Morell Frellsen appointed CCO of DanCann Pharma A/S as from April 1, 2021 to accelerate the Company’s European penetration
Press release from Companies: DanCann Pharma A/S: CEO Jeppe Krog Rasmussen upgrades his shareholding in DanCann Pharma A/S, and now holds more than 26% of the Company
